VOR
Vor Biopharma (VOR)
$
90About Vor Biopharma (VOR)
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.
Details
Daily high
$0.91
Daily low
$0.83
Price at open
$0.83
52 Week High
$2.43
52 Week Low
$0.63
Market cap
111.7M
Dividend yield
0.00%
Volume
272,038
Avg. volume
362,108
P/E ratio
-.54
Vor Biopharma News
Details
Daily high
$0.91
Daily low
$0.83
Price at open
$0.83
52 Week High
$2.43
52 Week Low
$0.63
Market cap
111.7M
Dividend yield
0.00%
Volume
272,038
Avg. volume
362,108
P/E ratio
-.54